Nexity Reim and Natixis Capital Partners's new joint venture, Capnexi, has bought a 17,000 m[sup]2[/sup] portfolio consisting of three assets at Puteaux outside Paris from German pharmaceutical group Bayer for EUR 105mln. In a statement, the two partners said that Bayer will lease back two of the buildings, or about 6,800 m[sup]2[/sup] of space. The third building will be renovated and put out to lease.
Nexity Reim and Natixis Capital Partners's new joint venture, Capnexi, has bought a 17,000 m2 portfolio consisting of three assets at Puteaux outside Paris from German pharmaceutical group Bayer for EUR 105mln. In a statement, the two partners said that Bayer will lease back two of the buildings, or about 6,800 m2 of space. The third building will be renovated and put out to lease.
Capnexi, the first OPCI investment vehicle dedicated exclusively to sale and lease back deals, will be managed by Ciloger, which is 60% owned by Natixis Capital Partners' Captiva Capital Partners III, and 40% by Nexity, the companies said.
The buyers were advised by Cabinet Gide Loirette Nouel, Etude Wargny Katz and the Cabinet Arsène Taxand.
The acquisition adds to the purchase of a 13,000 m2 office building in the 13th arrondissement of Paris from the French mail services company La Poste.
